Melissa Liebowitz1, Ronald I Clyman2. 1. Department of Pediatrics, University of California, San Francisco, San Francisco, CA. 2. Cardiovascular Research Institute and Department of Pediatrics, University of California San Francisco, San Francisco, CA. Electronic address: clymanr@peds.ucsf.edu.
Abstract
OBJECTIVE: To examine the effects of antenatal steroids on severe intraventricular hemorrhage (IVH) in infants born during the IVH vulnerable period (<28 weeks gestational age) and to evaluate rates of IVH correlated with the time interval between treatment or retreatment and birth. STUDY DESIGN: A total of 429 infants (<28 weeks gestation), who delivered ≥24 hours after the first betamethasone (BMZ) course (2 doses), were divided into groups based on the interval between the first course of BMZ and delivery: <10 days or ≥10 days. The primary outcome was severe IVH. Multiple regression analyses were performed to adjust for potential confounders. RESULTS: Three hundred ninety-two infants delivered after a single BMZ course (312 delivered <10 days; 80 ≥10 days). The incidence of severe IVH was 17% for infants delivered ≥10 days and 7% for those delivered <10 days after a single BMZ course (aOR 4.16; 95% CI 1.59-10.87, P = .004); 37 infants (born ≥10 days from the first BMZ course) received a second/rescue BMZ course. The incidence of severe IVH among infants receiving a second/rescue course was 8%, which was similar to the incidence among infants born <10 days (aOR 1.7; 95% CI 0.41-6.6, P = .48). CONCLUSIONS: In infants born before 28 weeks gestation, delivery ≥10 days from the first BMZ course is associated with a higher incidence of severe IVH; a second/rescue course may reverse this effect.
OBJECTIVE: To examine the effects of antenatal steroids on severe intraventricular hemorrhage (IVH) in infants born during the IVH vulnerable period (<28 weeks gestational age) and to evaluate rates of IVH correlated with the time interval between treatment or retreatment and birth. STUDY DESIGN: A total of 429 infants (<28 weeks gestation), who delivered ≥24 hours after the first betamethasone (BMZ) course (2 doses), were divided into groups based on the interval between the first course of BMZ and delivery: <10 days or ≥10 days. The primary outcome was severe IVH. Multiple regression analyses were performed to adjust for potential confounders. RESULTS: Three hundred ninety-two infants delivered after a single BMZ course (312 delivered <10 days; 80 ≥10 days). The incidence of severe IVH was 17% for infants delivered ≥10 days and 7% for those delivered <10 days after a single BMZ course (aOR 4.16; 95% CI 1.59-10.87, P = .004); 37 infants (born ≥10 days from the first BMZ course) received a second/rescue BMZ course. The incidence of severe IVH among infants receiving a second/rescue course was 8%, which was similar to the incidence among infants born <10 days (aOR 1.7; 95% CI 0.41-6.6, P = .48). CONCLUSIONS: In infants born before 28 weeks gestation, delivery ≥10 days from the first BMZ course is associated with a higher incidence of severe IVH; a second/rescue course may reverse this effect.
Authors: Deborah G Hirtz; Steven J Weiner; Dorothy Bulas; Michael DiPietro; Joanna Seibert; Dwight J Rouse; Brian M Mercer; Michael W Varner; Uma M Reddy; Jay D Iams; Ronald J Wapner; Yoram Sorokin; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall W Carpenter; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Donald Dudley; Steve N Caritis Journal: J Pediatr Date: 2015-08-05 Impact factor: 4.406
Authors: Melissa Catenacci; Shogo Miyagi; Andrea C Wickremasinghe; Sarah Scarpace Lucas; Alejandra G de Alba Campomanes; William V Good; Ronald I Clyman Journal: J Pediatr Date: 2013-03-01 Impact factor: 4.406
Authors: Barbara J Stoll; Nellie I Hansen; Edward F Bell; Michele C Walsh; Waldemar A Carlo; Seetha Shankaran; Abbot R Laptook; Pablo J Sánchez; Krisa P Van Meurs; Myra Wyckoff; Abhik Das; Ellen C Hale; M Bethany Ball; Nancy S Newman; Kurt Schibler; Brenda B Poindexter; Kathleen A Kennedy; C Michael Cotten; Kristi L Watterberg; Carl T D'Angio; Sara B DeMauro; William E Truog; Uday Devaskar; Rosemary D Higgins Journal: JAMA Date: 2015-09-08 Impact factor: 56.272
Authors: Elaine L Shelton; Nahid Waleh; Erin J Plosa; John T Benjamin; Ginger L Milne; Christopher W Hooper; Noah J Ehinger; Stanley Poole; Naoko Brown; Steven Seidner; Donald McCurnin; Jeff Reese; Ronald I Clyman Journal: Pediatr Res Date: 2018-07-06 Impact factor: 3.756
Authors: Jinglan Huang; Junjie Meng; Imti Choonara; Tao Xiong; Yibin Wang; Huiqing Wang; Yi Qu; Dezhi Mu Journal: Medicine (Baltimore) Date: 2019-08 Impact factor: 1.817
Authors: Jenna E Koschnitzky; Richard F Keep; David D Limbrick; James P McAllister; Jill A Morris; Jennifer Strahle; Yun C Yung Journal: Fluids Barriers CNS Date: 2018-03-27
Authors: Alan H Jobe; Matthew Kemp; Augusto Schmidt; Tsukasa Takahashi; John Newnham; Mark Milad Journal: Pediatr Res Date: 2020-11-11 Impact factor: 3.756